Tanya A. Villegas-Camacho

Guadalajara C.P. 44270
Guadalajara, JAL 44270, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

A vNAR-based hybrid nanobiosensor for rapid and selective HbA1c detection: a step forward in next-generation diabetes diagnosis.

A vNAR-based hybrid nanobiosensor for rapid and selective HbA1c detection: a step forward in next-generation diabetes diagnosis.

Journal: Nanoscale

Published: April 16, 2026

Theranostic vNAR-Based Immunoconjugates Achieve Selective Intracellular Cisplatin Delivery in Embedded 3D HER2-Positive Breast Cancer In Vitro Model.

Theranostic vNAR-Based Immunoconjugates Achieve Selective Intracellular Cisplatin Delivery in Embedded 3D HER2-Positive Breast Cancer In Vitro Model.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 06, 2026

Discovery and computational characterization of ZIKV envelope-targeted peptides from a subtractive phage display library.

Discovery and computational characterization of ZIKV envelope-targeted peptides from a subtractive phage display library.

Journal: PloS one

Published: October 21, 2025

Alginate-Gelatin Hydrogel Scaffold Model for Hypoxia Induction in Glioblastoma Embedded Spheroids.

Alginate-Gelatin Hydrogel Scaffold Model for Hypoxia Induction in Glioblastoma Embedded Spheroids.

Journal: Gels (Basel, Switzerland)

Published: March 12, 2025

Isolation and Characterization of the First Antigen-Specific EGFRvIII vNAR from Freshwater Stingray (Potamotrygon spp.) as a Drug Carrier in Glioblastoma Cancer Cells.

Isolation and Characterization of the First Antigen-Specific EGFRvIII vNAR from Freshwater Stingray (Potamotrygon spp.) as a Drug Carrier in Glioblastoma Cancer Cells.

Journal: International journal of molecular sciences

Published: December 19, 2024

vNARs as Neutralizing Intracellular Therapeutic Agents: Glioblastoma as a Target.

vNARs as Neutralizing Intracellular Therapeutic Agents: Glioblastoma as a Target.

Journal: Antibodies (Basel, Switzerland)

Published: November 27, 2023

Embedded Living HER2+ Cells in a 3D Gelatin-Alginate Hydrogel as an In Vitro Model for Immunotherapy Delivery for Breast Cancer.

Embedded Living HER2+ Cells in a 3D Gelatin-Alginate Hydrogel as an In Vitro Model for Immunotherapy Delivery for Breast Cancer.

Journal: Polymers

Published: July 27, 2023

In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2.

In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2.

Journal: Viruses

Published: April 15, 2023

First pan-specific vNAR against human TGF-β as a potential therapeutic application: in silico modeling assessment.

First pan-specific vNAR against human TGF-β as a potential therapeutic application: in silico modeling assessment.

Journal: Scientific reports

Published: December 14, 2022

3D Cell Culture as Tools to Characterize Rheumatoid Arthritis Signaling and Development of New Treatments.

3D Cell Culture as Tools to Characterize Rheumatoid Arthritis Signaling and Development of New Treatments.

Journal: Cells

Published: September 20, 2022

Possible Routes for Zika Virus Vertical Transmission in Human Placenta: A Comprehensive Review.

Possible Routes for Zika Virus Vertical Transmission in Human Placenta: A Comprehensive Review.

Journal: Viral immunology

Published: May 04, 2022

Potential Therapeutic Applications of Synthetic Conotoxin s-cal14.2b, Derived from Californiconus californicus, for Treating Type 2 Diabetes.

Potential Therapeutic Applications of Synthetic Conotoxin s-cal14.2b, Derived from Californiconus californicus, for Treating Type 2 Diabetes.

Journal: Biomedicines

Published: July 08, 2021

Showing 1-12 of 28

Last Updated: 09/26/2026